Company Filing History:
1 out of 153 
1 out of 12 Years Active: 2023
Title: Yong Luo: Innovator in Virology and Tumor Therapy
Introduction
Yong Luo is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of virology and tumor therapy through his innovative research and inventions. His work focuses on developing solutions that target tumor cells while minimizing side effects on normal cells.
Latest Patents
Yong Luo holds a patent for a recombinant herpes simplex virus (HSV) that is capable of specifically replicating at high levels in tumor cells. This invention effectively kills tumor cells while replicating at low levels in normal cells, thereby reducing side effects, particularly neurotoxicity. The recombinant herpes simplex virus can be utilized for gene drug delivery into tumor cells, making it a valuable tool for gene therapy.
Career Highlights
Throughout his career, Yong Luo has been associated with notable institutions such as Xiamen University. His work has garnered attention for its potential impact on cancer treatment and virology. His innovative approach to using recombinant viruses in therapy showcases his commitment to advancing medical science.
Collaborations
Yong Luo has collaborated with esteemed colleagues, including Chenghao Huang and Quan Yuan. These partnerships have contributed to the development and refinement of his groundbreaking inventions.
Conclusion
Yong Luo's contributions to virology and tumor therapy through his patented inventions highlight his role as an influential inventor in the medical field. His work not only advances scientific understanding but also offers hope for improved cancer treatments.